BAMS
UTHR icon

Bellevue Asset Management (Switzerland)’s United Therapeutics UTHR Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$1.46M Hold
9,300
– – 0.22% 95
2015
Q3 		$1.22M Hold
9,300
– – 0.2% 101
2015
Q2 		$1.62M Hold
9,300
– – 0.22% 99
2015
Q1 		$1.6M Buy
+9,300
New +$1.42M 0.22% 100

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s UTHR Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its United Therapeutics (UTHR) position steady in Q4 2015 at 9,300 shares worth $1.46M. The position accounts for 0.22% of the portfolio, ranked #95.

Bellevue Asset Management (Switzerland) first reported a position in UTHR in Q1 2015 and has held it in 4 quarters since. The position peaked at $1.62M in Q2 2015. 387 funds tracked by Wall St. Rank hold UTHR as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 9,300 shares of United Therapeutics worth $1.46M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its United Therapeutics share count unchanged in Q4 2015.
  • United Therapeutics made up 0.22% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #95 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in United Therapeutics in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s United Therapeutics position peaked at $1.62M in Q2 2015.
  • 387 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.